US Patent Issued to The United States of America, as represented by the Secretary, Department of Health and Human Services on Feb. 17 for "N-(3-amino-3-oxopropyl)-2-[(1-methyl-4-nitro-1H-imidazol-5-yl)thiobenzamide and its use for treating HIV infection" (Maryland, California, District Of Columbia Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,464, issued on Feb. 17, was assigned to The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.).

"N-(3-amino-3-oxopropyl)-2-[(1-methyl-4-nitro-1H-imidazol-5-yl)thiobenzamide and its use for treating HIV infection" was invented by Daniel H. Appella (Rockville, Md.), Herman Nikolayevskiy (Sausalito, Calif.), Marco Robello (Washington) and Michael T. Scerba (Baltimore).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a compound of formula (I): for treating or preventing a human immunodeficiency virus (HIV) infection in a mammal, for inhibiting or preventing maturation of an immatu...